Page last updated: 2024-12-08
4'-hydroxypropranolol sulfate ester
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4'-hydroxypropranolol sulfate ester: propranolol urinary metabolite; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 135862 |
| MeSH ID | M0121437 |
Synonyms (19)
| Synonym |
|---|
| 87075-33-0 |
| 4-[2-hydroxy-3-(propan-2-ylamino)propoxy]naphthalen-1-yl hydrogen sulfate |
| 1-naphthalenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 1-(hydrogen sulfate) |
| unii-frg22a758k |
| 4'-hydroxypropranolol sulfate |
| frg22a758k , |
| 4-hops |
| 4'-hydroxypropranolol sulfate ester |
| 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-1-naphthalenol 1-hydrogen sulfate |
| [4-[2-hydroxy-3-(propan-2-ylamino)propoxy]naphthalen-1-yl] hydrogen sulfate |
| FT-0670056 |
| 4-hydroxypropranolol-4-o-sulfate |
| 4-hydroxypropranolol sulfate ester |
| (+/-)-4'-hydroxy propranolol sulfate |
| Q27278151 |
| DTXSID201007316 |
| 4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}naphthalen-1-yl hydrogen sulfate |
| rac 4-sulfoxy propranolol |
| (+/-)-4hydroxy propranolol sulfate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Pathways (1)
| Pathway | Proteins | Compounds |
|---|---|---|
| Propranolol Pathway, Pharmacokinetics | 9 | 5 |
Research
Studies (4)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||